Thalidomide-O-amido-C6-NH2 (TFA), 500mg

(2,2-Dimethyl-1,3-dioxan-5-yl)methanol, 98.0%, 1g

3-(2-HYDROXYETHYL)BENZOIC ACID, 95.0%, 5g

(2'-(Trifluoromethyl)-[1,1'-biphenyl]-3-yl)methanamine, 95%, 500mg

1-Boc-3,5-Dimethylpiperazine, 95.0%, 100mg

(R)-3-(tert-Butoxycarbonyl)-5,5-dimethylthiazolidine-4-carboxylic acid, 95.0%, 250mg

Morpholine-2-carboxylic acid, 95.0%, 250mg

N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)aniline, 97%, 1g

2-Bromo-1-(2 furyl)-1-ethanone, 95.0%, 100mg

5-BROMO-2-HYDROXY-4-METHOXYBENZOIC ACID, 95.0%, 5g

Yoduro de acetiltiocolina, mínimo 99 %, para bioquímica, 1 g, envase de vidrio

ETHYL 2-(3-OXOCYCLOPENTYL)ACETATE, 95.0%, 1g

3-(3,4-dimethylphenyl)-4'-fluoropropiophenone, 97.0%, 1g